Melania Maione

Hi, my name is Melania, and I am 38 years old. In 2013, I obtained a degree in Medicine at the University of Milano Bicocca with a thesis entitled “Study of Molecular Mechanisms that Regulate Plasma Levels of BNP, a Potential Biomarker of Cardiac Dysfunction for Critically Ill Patients” after a period of translation research Massachusetts General Hospital Department of Anesthesia, Critical Care and Pain Medicine – Harvard University, School of Medicine. During the Medical School I completed the educational program abroad, in Paris and in USA, to get many insights into the responsibilities of management patients journey in different medical departments, both clinical and surgical. Throughout the internships, I was in charged with not only overseeing the patient care but also to assure workplace harmony. After entering my professional part as medical doctor at the main hospitals in Milan, the next step in pharmaceutical companies was natural. Nowadays, I am continuing inspired by the possibilities of science to make a difference and so I play a pivotal role in channeling scientific capabilities to make a positive impact on changing patients ‘lives. For my career to progress on the path I have chosen, obtained a Global Master of Public Health and the skills that go with it is essential. To be widely prepared and competitive in most fields a Global perspective was necessary, and I learned this crucial truth from my studies and my previous professional experiences. Since 2020, I am completing my experience running the Executive PhD research project in Neuroscience. Currently, I am collaborating with Prof G. Cavaletti and with Prof. S. Gerevini, Neuroradiology Department at ASST Papa Giovanni XXIII in Bergamo.

PhD research project

Explorative and Descriptive Analysis of Differential Diagnosis Algorithm with Nerve Magnetic Resonance Imaging (MRI) in Patients with Neuromuscular Diseases

The main aim of the research project would be to investigate the opportunity of using MRI to obtain data through a non-invasive method in patients with neuromuscular diseases and its potential application in clinics after a model validation. The research outcomes will lead to the differential diagnosis of peripheral neuropathies, especially neuroinflammation diseases, by looking at the nerve change level. Then, the final ambition would be to establish the use of nerve MRI as an endpoint of clinical trials and in clinical practice.